Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 5 | Journal of Translational Medicine

Fig. 5

From: C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation

Fig. 5

C14orf166 regulated the key proteins that regulate G1/S transition. a Cell cycle assay of the effect of C14orf166 knockdown on cell cycle progression. b Quantitative RT-PCR determination of Cyclin D1, P21, and P27 expression after C14orf166 knockdown in RT4 cells. Transcription levels were normalized to GAPDH expression. c Western blot determination of Cyclin D1, p21, p27, Rb, and p-Rb expression in RT4 cells. α-Tubulin was used as the loading control. d Quantitative RT-PCR determination of Cyclin D1, P21 and P27 expression following C14orf166 knockdown in T24 cells. Transcription levels were normalized to GAPDH expression. e Western blot determination of Cyclin D1, p21, p27, Rb, and p-Rb expression in T24 cells. α-Tubulin was used as the loading control. *P < 0.05

Back to article page